Anda Biopharma
Anda Biopharma develops personalized cancer vaccines that train a patient’s immune system to target tumor-specific neoantigens. The company combines tumor genomics, immunology and vaccinology with AI-driven neoantigen prediction to design individualized therapeutic vaccines. Its platform integrates genomic sequencing data and computational antigen-ranking to select vaccine targets and guide vaccine formulation. Anda Biopharma operates as a biotech developer working with clinical and pharmaceutical partners to advance personalized oncology therapeutics.
Anda Biopharma
Anda Biopharma develops personalized cancer vaccines that train a patient’s immune system to target tumor-specific neoantigens. The company combines tumor genomics, immunology and vaccinology with AI-driven neoantigen prediction to design individualized therapeutic vaccines. Its platform integrates genomic sequencing data and computational antigen-ranking to select vaccine targets and guide vaccine formulation. Anda Biopharma operates as a biotech developer working with clinical and pharmaceutical partners to advance personalized oncology therapeutics.